• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4637633)   Today's Articles (4427)   Subscriber (50154)
For: Jacoby GA, Sutton L. beta-Lactamases and beta-lactam resistance in Escherichia coli. Antimicrob Agents Chemother 1985;28:703-5. [PMID: 3911882 PMCID: PMC176364 DOI: 10.1128/aac.28.5.703] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]  Open
Number Cited by Other Article(s)
1
Caesar LK, Cech NB. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. Nat Prod Rep 2019;36:869-888. [PMID: 31187844 PMCID: PMC6820002 DOI: 10.1039/c9np00011a] [Citation(s) in RCA: 353] [Impact Index Per Article: 70.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
2
Antibiotics for Emerging Pathogens. Infect Dis (Lond) 2013. [DOI: 10.1007/978-1-4614-5719-0_2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]  Open
3
Comparative activity of cefepime with several antimicrobials against aerobic Gram-negative and Gram-positive organisms isolated from patients across Canada in 1993. Can J Infect Dis 2012;6:258-62. [PMID: 22514408 DOI: 10.1155/1995/458762] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
4
In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study. Can J Infect Dis 2012;10:122-7. [PMID: 22346377 DOI: 10.1155/1999/172031] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/1998] [Accepted: 09/16/1998] [Indexed: 01/25/2023]  Open
5
Antibiotics for Emerging Pathogens. Infect Dis (Lond) 2012. [DOI: 10.1007/978-1-0716-2463-0_523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]  Open
6
Kurpiel PM, Hanson ND. Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of blaCMY-2 and resistance to piperacillin/tazobactam in Escherichia coli. J Antimicrob Chemother 2011;67:339-45. [DOI: 10.1093/jac/dkr479] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]  Open
7
Tavio MM, Aquili VD, Poveda JB, Antunes NT, Sanchez-Cespedes J, Vila J. Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli. J Antimicrob Chemother 2010;65:1178-86. [DOI: 10.1093/jac/dkq112] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]  Open
8
Integron mobilization unit as a source of mobility of antibiotic resistance genes. Antimicrob Agents Chemother 2009;53:2492-8. [PMID: 19332679 DOI: 10.1128/aac.00033-09] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]  Open
9
Docobo-Pérez F, Fernández-Cuenca F, Pachón-Ibáñez M, Pascual A, Pichardo C, Martínez-Martínez L, Pachón J. Efficacy of amoxycillin–clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin. Clin Microbiol Infect 2008;14:582-7. [DOI: 10.1111/j.1469-0691.2008.01948.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
10
Lartigue MF, Poirel L, Poyart C, Réglier-Poupet H, Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007;13:315-7. [PMID: 17479901 PMCID: PMC2725854 DOI: 10.3201/eid1302.060747] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]  Open
11
Poirel L, Héritier C, Spicq C, Nordmann P. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 2004;42:3831-3. [PMID: 15297541 PMCID: PMC497580 DOI: 10.1128/jcm.42.8.3831-3833.2004] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
12
Zhang YL, Li JT, Zhao MW. Detection of amp C in Enterobacter cloacae in China. Int J Antimicrob Agents 2001;18:365-71. [PMID: 11691570 DOI: 10.1016/s0924-8579(01)00414-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
13
Martínez-Martínez L, Conejo MC, Pascual A, Hernández-Allés S, Ballesta S, Ramírez De Arellano-Ramos E, Benedí VJ, Perea EJ. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob Agents Chemother 2000;44:2534-6. [PMID: 10952609 PMCID: PMC90099 DOI: 10.1128/aac.44.9.2534-2536.2000] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
14
Nelson EC, Elisha BG. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1999;43:957-9. [PMID: 10103209 PMCID: PMC89235 DOI: 10.1128/aac.43.4.957] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
15
Caniça MM, Lu CY, Krishnamoorthy R, Paul GC. Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli. J Mol Evol 1997;44:57-65. [PMID: 9010136 DOI: 10.1007/pl00006121] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
16
Massidda O, Montanari MP, Mingoia M, Varaldo PE. Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins. Antimicrob Agents Chemother 1996;40:2769-74. [PMID: 9124838 PMCID: PMC163619 DOI: 10.1128/aac.40.12.2769] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]  Open
17
Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). Antimicrob Agents Chemother 1996;40:1736-40. [PMID: 8807075 PMCID: PMC163408 DOI: 10.1128/aac.40.7.1736] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]  Open
18
Nicolas-Chanoine M. Impact of β-lactamases on the clinical use of β-lactam antibiotics. Int J Antimicrob Agents 1996;7 Suppl 1:S21-6. [DOI: 10.1016/0924-8579(96)00315-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
19
Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84. [PMID: 8665470 PMCID: PMC172876 DOI: 10.1128/cmr.8.4.557] [Citation(s) in RCA: 1036] [Impact Index Per Article: 35.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]  Open
20
Bradford PA, Sanders CC. Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics. Antimicrob Agents Chemother 1995;39:308-13. [PMID: 7726487 PMCID: PMC162532 DOI: 10.1128/aac.39.2.308] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]  Open
21
Scriver SR, Walmsley SL, Kau CL, Hoban DJ, Brunton J, McGeer A, Moore TC, Witwicki E. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother 1994;38:1678-80. [PMID: 7979309 PMCID: PMC284617 DOI: 10.1128/aac.38.7.1678] [Citation(s) in RCA: 81] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]  Open
22
Nowé P. Piperacillin/tazobactam in complicated urinary tract infections. Intensive Care Med 1994;20 Suppl 3:S39-42. [PMID: 7962988 DOI: 10.1007/bf01745250] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
23
Massidda O, Montanari MP, Mingoia M, Varaldo PE. Cloning and expression of the penicillinase from a borderline methicillin-susceptible Staphylococcus aureus strain in Escherichia coli. FEMS Microbiol Lett 1994;119:263-9. [PMID: 8050709 DOI: 10.1111/j.1574-6968.1994.tb06899.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]  Open
24
Barradell LB, Bryson HM. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;47:471-505. [PMID: 7514976 DOI: 10.2165/00003495-199447030-00007] [Citation(s) in RCA: 110] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
25
Kieft H, Hoepelman AI, Rozenberg-Arska M, Branger JM, Voskuil JH, Geers AB, Kluyver M, Hart HC, Poest-Clement E, van Beugen L. Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome. Antimicrob Agents Chemother 1994;38:415-21. [PMID: 8203833 PMCID: PMC284473 DOI: 10.1128/aac.38.3.415] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]  Open
26
Okamoto MP, Nakahiro RK, Chin A, Bedikian A. Cefepime clinical pharmacokinetics. Clin Pharmacokinet 1993;25:88-102. [PMID: 8403741 DOI: 10.2165/00003088-199325020-00002] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
27
Arstila T, Huovinen S, Huovinen P. Problems in interpretation of piperacillin susceptibility of TEM-1 producing Escherichia coli in the disk diffusion test. Eur J Clin Microbiol Infect Dis 1991;10:1066-7. [PMID: 1802698 DOI: 10.1007/bf01984931] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
28
Pucci MJ, Boice-Sowek J, Kessler RE, Dougherty TJ. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrob Agents Chemother 1991;35:2312-7. [PMID: 1804003 PMCID: PMC245377 DOI: 10.1128/aac.35.11.2312] [Citation(s) in RCA: 60] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]  Open
29
Takesue Y, Yokoyama T, Kodama T, Murakami Y, Sewake H, Miyamoto K, Imamura Y, Tsumura H, Matsuura Y. The influence of clinical use of antibiotics and the sensitivity of strains isolated from postoperative infections--a comparison of nosocomial pathogens with strains isolated from the bacterial flora of patients. THE JAPANESE JOURNAL OF SURGERY 1991;21:376-80. [PMID: 1960895 DOI: 10.1007/bf02470964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
30
Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990;34:2200-9. [PMID: 1963529 PMCID: PMC172023 DOI: 10.1128/aac.34.11.2200] [Citation(s) in RCA: 193] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]  Open
31
Jacoby GA, Carreras I. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1990;34:858-62. [PMID: 2193623 PMCID: PMC171706 DOI: 10.1128/aac.34.5.858] [Citation(s) in RCA: 165] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]  Open
32
Cooksey R, Swenson J, Clark N, Gay E, Thornsberry C. Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States. Antimicrob Agents Chemother 1990;34:739-45. [PMID: 2193616 PMCID: PMC171683 DOI: 10.1128/aac.34.5.739] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]  Open
33
Hiraoka M, Okamoto R, Inoue M, Mitsuhashi S. Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli. Antimicrob Agents Chemother 1989;33:382-6. [PMID: 2658786 PMCID: PMC171497 DOI: 10.1128/aac.33.3.382] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
34
Reguera JA, Baquero F, Perez-Diaz JC, Martinez JL. Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance. Eur J Clin Microbiol Infect Dis 1988;7:778-9. [PMID: 3145862 DOI: 10.1007/bf01975047] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
35
Matsumoto Y, Ikeda F, Kamimura T, Yokota Y, Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother 1988;32:1243-6. [PMID: 3056257 PMCID: PMC172385 DOI: 10.1128/aac.32.8.1243] [Citation(s) in RCA: 101] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
36
Pelosi E, Fontana R. In vitro activity and beta-lactamase stability of LY163892. Eur J Clin Microbiol Infect Dis 1988;7:549-51. [PMID: 3141170 DOI: 10.1007/bf01962613] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
37
Paul G, Barthélémy M, Philippon A, Peduzzi J, Gilly L, Labia R, Névot P. Immunological comparison of constitutive β-lactamases of gram-negative bacteria by neutralization in zymogram gels: Properties of anti-TEM-1 and anti-TEM-2 sera. ACTA ACUST UNITED AC 1988. [DOI: 10.1016/0769-2609(88)90106-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
38
Huovinen S, Huovinén P, Jacoby GA. Detection of plasmid-mediated beta-lactamases with DNA probes. Antimicrob Agents Chemother 1988;32:175-9. [PMID: 3259120 PMCID: PMC172130 DOI: 10.1128/aac.32.2.175] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]  Open
39
Morin CJ, Patel PC, Levesque RC, Letarte R. Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase. Antimicrob Agents Chemother 1987;31:1761-7. [PMID: 2449122 PMCID: PMC175035 DOI: 10.1128/aac.31.11.1761] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]  Open
40
Vu Thien H, Baudon J, Rolland M. Salmonella typhimurium : Résistance aux céphalosporines de troisième génération. Med Mal Infect 1987. [DOI: 10.1016/s0399-077x(87)80049-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
41
Scavizzi MR, Alonso JM, Philippon AM, Jupeau-Vessieres AM, Guiyoule A. Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection. Antimicrob Agents Chemother 1987;31:523-6. [PMID: 3475033 PMCID: PMC174770 DOI: 10.1128/aac.31.4.523] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]  Open
42
Livermore DM. Mechanisms of resistance to cephalosporin antibiotics. Drugs 1987;34 Suppl 2:64-88. [PMID: 3319506 DOI: 10.2165/00003495-198700342-00007] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
43
Bêta-lactamases : identification, rôle, aspects épidémiologiques. Med Mal Infect 1986. [DOI: 10.1016/s0399-077x(86)80003-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
44
Philippon AM, Paul GC, Thabaut AP, Jacoby GA. Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1986;29:519-20. [PMID: 3087285 PMCID: PMC180426 DOI: 10.1128/aac.29.3.519] [Citation(s) in RCA: 30] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA